56 results match your criteria: "and Hebrew University Faculty of Medicine[Affiliation]"
Research ethics committee approval as reported for abstracts submitted to the annual Euroanaesthesia meeting.
Eur J Anaesthesiol
December 2017
From the Department of Anaesthesia and Intensive Care Medicine, Royal Alexandra Hospital, Paisley, UK (PMc), the Intensive Care Unit, Shaare Zedek Medical Center, Jerusalem, Israel (NK), the Department of Anaesthesiology, Ghent University Hospital, Ghent University, Ghent, Belgium (SDH), the Department of Anaesthesiology, Cochin and Hôtel-Dieu University Hospitals, Paris Descartes University, Paris, France (MCS), the Department of Anaesthesiology and Intensive Therapy, University of Szeged, Szeged, Hungary (ZM), and the Department of Anaesthesia and Intensive Care, Shaare Zedek Medical Center and Hebrew University Faculty of Medicine, Jerusalem, Israel (SE).
Background: The annual congress of the European Society of Anaesthesiology (ESA) is one of the largest anaesthesia congresses in the world and exhibits more than 1200 abstracts annually.
Objectives: The aims of this study were to quantify the frequency of inadequate evidence of ethical approval for abstracts submitted to the ESA congress and to examine whether abstracts without appropriate ethical approval were subsequently accepted.
Design And Setting: All abstracts submitted in 2015 were adjudicated according to European ethical criteria.
In Response.
Anesth Analg
August 2017
Department of Anesthesiology and Critical Care Medicine, Hadassah Hebrew University Medical Center, Jerusalem, Israel, Department of Anesthesiology, Department of Perioperative and Pain Medicine Stanford University School of Medicine, Stanford, California Intensive Care Unit, Shaare Zedek Medical Center and Hebrew University Faculty of Medicine, Jerusalem, Israel.
Analysis of Physiological Respiratory Variable Alarm Alerts Among Laboring Women Receiving Remifentanil.
Anesth Analg
April 2017
From the *Department of Anesthesiology and Critical Care Medicine, Hadassah Hebrew University Medical Center, Jerusalem, Israel; †Department of Anesthesiology, Perioperative and Pain Medicine Stanford University School of Medicine, Stanford, California; ‡Department of Anesthesiology and Intensive Care, Tel Aviv Medical Center, Tel Aviv, Israel; and §Intensive Care Unit, Shaare Zedek Medical Center and Hebrew University Faculty of Medicine, Jerusalem, Israel.
Background: Remifentanil may be used by laboring women for analgesia, despite controversy because of potential apneas. We evaluated candidate variables as early warning alerts for apnea, based on prevalence, positive predictive rate, sensitivity for apnea event detection, and early warning alert time intervals (lead time) for apnea.
Methods: We performed a secondary analysis of respiratory physiological data that had been collected during a prospective IRB-approved study of laboring women receiving IV patient-controlled boluses of remifentanil 20 to 60 μg every 1 to 2 minutes.
Erratum to: Visit to intensive care of 2050.
Intensive Care Med
January 2017
Facultad de Medicina y Psicología, Universidad Autónoma de Baja California, Tijuana, Baja California, Mexico.
Visit to intensive care of 2050.
Intensive Care Med
January 2017
Facultad de Medicina y Psicología, Universidad Autónoma de Baja California, Tijuana, Baja California, Mexico.
The Israeli field hospital in Haiti--ethical dilemmas in early disaster response.
N Engl J Med
March 2010
Trauma Unit and Department of Cardiothoracic Surgery, Shaare Zedek Medical Center, and Hebrew University Faculty of Medicine, Jerusalem, Israel.